Literature DB >> 30473034

Portuguese consensus document for the management of alpha-1-antitrypsin deficiency.

A P Lopes1, M A Mineiro2, F Costa3, J Gomes4, C Santos5, C Antunes5, D Maia2, R Melo6, M Canotilho7, E Magalhães8, I Vicente8, C Valente9, B G Gonçalves10, B Conde11, C Guimarães12, C Sousa13, J Amado14, M E Brandão11, M Sucena13, M J Oliveira15, S Seixas16, V Teixeira17, L Telo5.   

Abstract

Alpha-1-antitrypsin deficiency (AATD) is a genetic autosomal codominant disorder caused by mutations in SERPINA1 gene. It is one of the most prevalent genetic disorders, although it remains underdiagnosed. Whereas at international level there are several areas of consensus on this disorder, in Portugal, inter-hospital heterogeneity in clinical practice and resources available have been adding difficulties in reaching a diagnosis and in making therapeutic decisions in this group of patients. This raised a need to draft a document expressing a national consensus for AATD. To this end, a group of experts in this field was created within the Portuguese Pulmonology Society - Study group on AATD, in order to elaborate the current manuscript. The authors reviewed the existing literature and provide here general guidance and extensive recommendations for the diagnosis and management of AATD that can be adopted by Portuguese clinicians from different areas of Medicine. This article is part of a supplement entitled "Portuguese consensus document for the management of alpha-1-antitrypsin deficiency" which is sponsored by Sociedade Portuguesa de Pneumologia.
Copyright © 2018. Published by Elsevier España, S.L.U.

Entities:  

Keywords:  Alpha 1-Antitrypsin Deficiency; Consensus; Diagnosis; Pulmonary Emphysema; Therapeutics

Mesh:

Year:  2018        PMID: 30473034     DOI: 10.1016/j.pulmoe.2018.09.004

Source DB:  PubMed          Journal:  Pulmonology        ISSN: 2531-0429


  6 in total

Review 1.  Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature.

Authors:  Evi Jaspers; Ine Van Dijck; Ilse Hoffman; Noël Knops; Xavier Stéphenne; Peter Witters; Marijke Proesmans
Journal:  BMC Pediatr       Date:  2022-05-03       Impact factor: 2.567

Review 2.  Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum.

Authors:  Susana Seixas; Patricia Isabel Marques
Journal:  Appl Clin Genet       Date:  2021-03-22

3.  A rare mutation on alpha-1 antitrypsin deficit and lung fibrosis: case report.

Authors:  Miguel Afonso; Clara Silva; Inês Pinho; Artur Vale; Ana Fernandes
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-12-16       Impact factor: 0.670

4.  Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.

Authors:  Timm Greulich; Anna Albert; Werner Cassel; Tobias Boeselt; Erika Peychev; Andreas Klemmer; Francini Ferreira; Christian Clarenbach; Maria L Torres-Duran; Alice M Turner; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-05

Review 5.  Treatable Traits in COPD - A Proposed Approach.

Authors:  João Cardoso; António Jorge Ferreira; Miguel Guimarães; Ana Sofia Oliveira; Paula Simão; Maria Sucena
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-11-18

6.  Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil.

Authors:  José R Jardim; Francisco Casas-Maldonado; Frederico Leon Arrabal Fernandes; Maria Vera Cruz de O Castellano; María Torres-Durán; Marc Miravitlles
Journal:  J Bras Pneumol       Date:  2021-05-31       Impact factor: 2.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.